Optimal risk factor modification and medical management of the patient with peripheral arterial disease

Yung-wei Chi, Michael R. Jaff

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Peripheral arterial occlusive disease (PAD) is a highly prevalent atherosclerotic syndrome associated with significant morbidity and mortality. It is defined by atherosclerotic obstruction of the abdominal aorta and arteries to the legs that reduces arterial flow during exercise and/or at rest, and is a common manifestation of systemic atherosclerosis. PAD represents a marker for premature cardiovascular events, and in patients with PAD, even in the absence of a history of myocardial infarction (MI) or ischemic stroke, they have approximately the same relative risk of death from cardiovascular causes as do patients with a history of coronary or cerebrovascular disease. In addition, their death rate from all causes is approximately equal in men and women and is elevated even in asymptomatic patients. The major risk factors for PAD are the well defined atherosclerotic risks such as diabetes mellitus, cigarette smoking, advanced age, hyperlipidemia, and hypertension. Due to the presence of these risk factors, the systemic nature of atherosclerosis, and the high risk of ischemic events, patients with PAD should be candidates for aggressive secondary prevention strategies including aggressive risk factor modification, antiplatelet therapy, lipid lowering therapy and antihypertensive treatment. This article reviews the current medical treatment and risk factor modification of patients with PAD.

Original languageEnglish (US)
Pages (from-to)475-489
Number of pages15
JournalCatheterization and Cardiovascular Interventions
Volume71
Issue number4
DOIs
StatePublished - Mar 1 2008
Externally publishedYes

Fingerprint

Arterial Occlusive Diseases
Peripheral Arterial Disease
Atherosclerosis
Cerebrovascular Disorders
Mortality
Abdominal Aorta
Therapeutics
Secondary Prevention
Hyperlipidemias
Antihypertensive Agents
Coronary Disease
Cause of Death
Leg
Diabetes Mellitus
Arteries
Smoking
Stroke
Myocardial Infarction
Exercise
Hypertension

Keywords

  • Medical management
  • Peripheral arterial occlusive disease
  • Risk factor modification

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Optimal risk factor modification and medical management of the patient with peripheral arterial disease. / Chi, Yung-wei; Jaff, Michael R.

In: Catheterization and Cardiovascular Interventions, Vol. 71, No. 4, 01.03.2008, p. 475-489.

Research output: Contribution to journalArticle

@article{293f38a635414547ad2546ca51d7d317,
title = "Optimal risk factor modification and medical management of the patient with peripheral arterial disease",
abstract = "Peripheral arterial occlusive disease (PAD) is a highly prevalent atherosclerotic syndrome associated with significant morbidity and mortality. It is defined by atherosclerotic obstruction of the abdominal aorta and arteries to the legs that reduces arterial flow during exercise and/or at rest, and is a common manifestation of systemic atherosclerosis. PAD represents a marker for premature cardiovascular events, and in patients with PAD, even in the absence of a history of myocardial infarction (MI) or ischemic stroke, they have approximately the same relative risk of death from cardiovascular causes as do patients with a history of coronary or cerebrovascular disease. In addition, their death rate from all causes is approximately equal in men and women and is elevated even in asymptomatic patients. The major risk factors for PAD are the well defined atherosclerotic risks such as diabetes mellitus, cigarette smoking, advanced age, hyperlipidemia, and hypertension. Due to the presence of these risk factors, the systemic nature of atherosclerosis, and the high risk of ischemic events, patients with PAD should be candidates for aggressive secondary prevention strategies including aggressive risk factor modification, antiplatelet therapy, lipid lowering therapy and antihypertensive treatment. This article reviews the current medical treatment and risk factor modification of patients with PAD.",
keywords = "Medical management, Peripheral arterial occlusive disease, Risk factor modification",
author = "Yung-wei Chi and Jaff, {Michael R.}",
year = "2008",
month = "3",
day = "1",
doi = "10.1002/ccd.21401",
language = "English (US)",
volume = "71",
pages = "475--489",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Optimal risk factor modification and medical management of the patient with peripheral arterial disease

AU - Chi, Yung-wei

AU - Jaff, Michael R.

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Peripheral arterial occlusive disease (PAD) is a highly prevalent atherosclerotic syndrome associated with significant morbidity and mortality. It is defined by atherosclerotic obstruction of the abdominal aorta and arteries to the legs that reduces arterial flow during exercise and/or at rest, and is a common manifestation of systemic atherosclerosis. PAD represents a marker for premature cardiovascular events, and in patients with PAD, even in the absence of a history of myocardial infarction (MI) or ischemic stroke, they have approximately the same relative risk of death from cardiovascular causes as do patients with a history of coronary or cerebrovascular disease. In addition, their death rate from all causes is approximately equal in men and women and is elevated even in asymptomatic patients. The major risk factors for PAD are the well defined atherosclerotic risks such as diabetes mellitus, cigarette smoking, advanced age, hyperlipidemia, and hypertension. Due to the presence of these risk factors, the systemic nature of atherosclerosis, and the high risk of ischemic events, patients with PAD should be candidates for aggressive secondary prevention strategies including aggressive risk factor modification, antiplatelet therapy, lipid lowering therapy and antihypertensive treatment. This article reviews the current medical treatment and risk factor modification of patients with PAD.

AB - Peripheral arterial occlusive disease (PAD) is a highly prevalent atherosclerotic syndrome associated with significant morbidity and mortality. It is defined by atherosclerotic obstruction of the abdominal aorta and arteries to the legs that reduces arterial flow during exercise and/or at rest, and is a common manifestation of systemic atherosclerosis. PAD represents a marker for premature cardiovascular events, and in patients with PAD, even in the absence of a history of myocardial infarction (MI) or ischemic stroke, they have approximately the same relative risk of death from cardiovascular causes as do patients with a history of coronary or cerebrovascular disease. In addition, their death rate from all causes is approximately equal in men and women and is elevated even in asymptomatic patients. The major risk factors for PAD are the well defined atherosclerotic risks such as diabetes mellitus, cigarette smoking, advanced age, hyperlipidemia, and hypertension. Due to the presence of these risk factors, the systemic nature of atherosclerosis, and the high risk of ischemic events, patients with PAD should be candidates for aggressive secondary prevention strategies including aggressive risk factor modification, antiplatelet therapy, lipid lowering therapy and antihypertensive treatment. This article reviews the current medical treatment and risk factor modification of patients with PAD.

KW - Medical management

KW - Peripheral arterial occlusive disease

KW - Risk factor modification

UR - http://www.scopus.com/inward/record.url?scp=41649091055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41649091055&partnerID=8YFLogxK

U2 - 10.1002/ccd.21401

DO - 10.1002/ccd.21401

M3 - Article

C2 - 18307227

AN - SCOPUS:41649091055

VL - 71

SP - 475

EP - 489

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 4

ER -